Covered recipient · General Payments record
GINNY ANN WALTON
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2022–2024
$4,830.02
- Reported across 208 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,497.20 | 51 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| UCB, Inc. | $211.03 | 8 |
| Neurelis, Inc. | $166.42 | 6 |
| Lundbeck LLC | $141.98 | 4 |
| SK Life Science, Inc. | $137.18 | 2 |
| EISAI INC. | $134.87 | 6 |
| Alexion Pharmaceuticals, Inc. | $122.75 | 1 |
| LivaNova USA, Inc. | $110.46 | 3 |
| Lilly USA, LLC | $96.92 | 6 |
| TG THERAPEUTICS, INC. | $85.66 | 1 |
| PFIZER INC. | $65.65 | 3 |
| Genentech USA, Inc. | $52.36 | 3 |
| BOSTON SCIENTIFIC CORPORATION | $51.50 | 2 |
| Novocure Inc. | $25.96 | 1 |
| TerSera Therapeutics LLC | $22.33 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $21.07 | 1 |
| ABBVIE INC. | $18.90 | 1 |
| CSL Behring | $17.75 | 1 |
| Biogen, Inc. | $14.41 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (51)
Sorted by paying entity, then date · as published by CMS
Program year 2024 20222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $18.90 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108376293 | CMS |
| Alexion Pharmaceuticals, Inc. | $122.75 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1093903811 | CMS |
| Biogen, Inc. | $14.41 | 09/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104827522 | CMS |
| Boston Scientific Corporation | $24.37 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092345038 | CMS |
| Boston Scientific Corporation | $27.13 | 07/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092345040 | CMS |
| CSL Behring | $17.75 | 04/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134650907 | CMS |
| Eisai Inc. | $22.12 | 02/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110802406 | CMS |
| Eisai Inc. | $23.61 | 04/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110802404 | CMS |
| Eisai Inc. | $17.03 | 06/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110802408 | CMS |
| Eisai Inc. | $26.24 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110802410 | CMS |
| Eisai Inc. | $22.12 | 09/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110802402 | CMS |
| Eisai Inc. | $23.75 | 11/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110802412 | CMS |
| Genentech USA, Inc. | $18.73 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133159447 | CMS |
| Genentech USA, Inc. | $19.94 | 10/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133159439 | CMS |
| Genentech USA, Inc. | $13.69 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133159443 | CMS |
| Lilly USA, LLC | $16.51 | 01/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135639502 | CMS |
| Lilly USA, LLC | $15.90 | 02/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135682949 | CMS |
| Lilly USA, LLC | $18.08 | 03/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135682951 | CMS |
| Lilly USA, LLC | $15.83 | 04/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135661251 | CMS |
| Lilly USA, LLC | $15.19 | 08/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135639504 | CMS |
| Lilly USA, LLC | $15.41 | 09/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135675256 | CMS |
| LivaNova USA, Inc. | $29.11 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152797833 | CMS |
| LivaNova USA, Inc. | $36.12 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152797847 | CMS |
| LivaNova USA, Inc. | $45.23 | 12/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152797951 | CMS |
| Lundbeck LLC | $17.14 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146104355 | CMS |
| Lundbeck LLC | $14.65 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146104357 | CMS |
| Lundbeck LLC | $28.94 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146104359 | CMS |
| Lundbeck LLC | $81.25 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146104361 | CMS |
| Neurelis, Inc. | $14.75 | 02/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145671990 | CMS |
| Neurelis, Inc. | $13.71 | 03/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145671992 | CMS |
| Neurelis, Inc. | $97.83 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145671994 | CMS |
| Neurelis, Inc. | $12.61 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145671996 | CMS |
| Neurelis, Inc. | $16.17 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145671998 | CMS |
| Neurelis, Inc. | $11.35 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145672000 | CMS |
| Novocure Inc. | $25.96 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1123335455 | CMS |
| PFIZER INC. | $17.99 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131361214 | CMS |
| PFIZER INC. | $22.32 | 07/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131760870 | CMS |
| PFIZER INC. | $25.34 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131950936 | CMS |
| SK Life Science, Inc. | $13.55 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154136278 | CMS |
| SK Life Science, Inc. | $123.63 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154136406 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $21.07 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137840737 | CMS |
| TerSera Therapeutics LLC | $22.33 | 06/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144721121 | CMS |
| TG Therapeutics, Inc. | $85.66 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136876546 | CMS |
| UCB, Inc. | $2.33 | 01/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143029186 | CMS |
| UCB, Inc. | $16.44 | 01/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143029188 | CMS |
| UCB, Inc. | $29.04 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143164203 | CMS |
| UCB, Inc. | $42.50 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143164205 | CMS |
| UCB, Inc. | $27.19 | 04/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143164207 | CMS |
| UCB, Inc. | $27.82 | 05/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143164209 | CMS |
| UCB, Inc. | $31.19 | 06/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143164211 | CMS |
| UCB, Inc. | $34.52 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143164213 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.